<DOC>
	<DOCNO>NCT00423254</DOCNO>
	<brief_summary>The present clinical trial dose comparison multi-component active immunotherapy design stimulate immune reaction specific tumor associate antigens highly express large number solid cancer .</brief_summary>
	<brief_title>Safety Immune Response Multi-component Immune Based Therapy ( MKC1106-PP ) Patients With Advanced Cancer .</brief_title>
	<detailed_description>The majority tumor ignore immune system think long time tumor antigen exist . However , recently number tumor antigens describe . These antigen reside cancer cell recognize specific T-cells ultimately attack destroy tumor .</detailed_description>
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Sarcoma</mesh_term>
	<mesh_term>Stomach Neoplasms</mesh_term>
	<mesh_term>Liver Neoplasms</mesh_term>
	<mesh_term>Mesothelioma</mesh_term>
	<mesh_term>Thyroid Neoplasms</mesh_term>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Endometrial Neoplasms</mesh_term>
	<mesh_term>Biliary Tract Neoplasms</mesh_term>
	<mesh_term>Gallbladder Neoplasms</mesh_term>
	<mesh_term>Esophageal Neoplasms</mesh_term>
	<mesh_term>Small Cell Lung Carcinoma</mesh_term>
	<mesh_term>Testicular Neoplasms</mesh_term>
	<mesh_term>Pancreatic Neoplasms</mesh_term>
	<mesh_term>Osteosarcoma</mesh_term>
	<mesh_term>Anus Neoplasms</mesh_term>
	<criteria>18 year age old Advanced , refractory solid malignancy histologically proven Measurable disease ECOG performance status 0 , 1 2 Adequate bone marrow reserve evidence Absolute neutrophil count ( ANC ) = 1,500/microL ; Platelet count = 100,000/microL Adequate renal hepatic function evidence serum creatinine = 1.5 mg/dL ; Serum total bilirubin = 2.0 mg/dL ; Alkaline phosphatase = 3X ULN reference lab ( = 5 ULN reference lab subject know hepatic metastasis ) ; SGOT/SGPT = 3X ULN reference lab ( = 5 ULN reference lab subject know hepatic metastasis ) Symptomatic central nervous system ( CNS ) metastases Any autoimmune disorder Positive HIV , hepatitis B hepatitis C antibody test Any allogeneic transplant Congestive heart failure Affected inguinal lymph node ( metastatic process ) lack inguinal lymph node ( resection )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2010</verification_date>
	<keyword>Cancer Vaccine</keyword>
</DOC>